NCT05606614Phase 3Active not recruiting

A Phase 1/2/3 Study of TSHA-102 Gene Therapy in Females With Rett Syndrome (REVEAL Pivotal Study)

Study sponsor: Taysha Gene Therapies, Inc. · TSHA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2031-06Estimated
Enrollment · participants17Actual
Source updated2026-07-07Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 15 participants (planned). After: 17 participants (actual).

Recruitment status changed

Before: Recruiting. After: Active not recruiting.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview